Leap Therapeutics Stock Price History

LPTX Stock  USD 0.52  0.05  8.77%   
Below is the normalized historical share price chart for Leap Therapeutics extending back to January 25, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Leap Therapeutics stands at 0.52, as last reported on the 31st of January, with the highest price reaching 0.57 and the lowest price hitting 0.51 during the day.
IPO Date
25th of January 2017
200 Day MA
2.6835
50 Day MA
2.8466
Beta
0.217
 
Covid
If you're considering investing in Leap Stock, it is important to understand the factors that can impact its price. Leap Therapeutics has Sharpe Ratio of -0.21, which conveys that the firm had a -0.21 % return per unit of risk over the last 3 months. Leap Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Leap Therapeutics' Mean Deviation of 5.58, risk adjusted performance of (0.13), and Standard Deviation of 10.63 to check out the risk estimate we provide.
  
At this time, Leap Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 106.3 K in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 45.2 M in 2025. . Price Earnings To Growth Ratio is likely to rise to 0.07 in 2025, whereas Price To Sales Ratio is likely to drop 109.75 in 2025. Leap Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2108

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsLPTX

Estimated Market Risk

 10.67
  actual daily
95
95% of assets are less volatile

Expected Return

 -2.25
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.21
  actual daily
0
Most of other assets perform better
Based on monthly moving average Leap Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Leap Therapeutics by adding Leap Therapeutics to a well-diversified portfolio.
Price Book
0.4474
Enterprise Value Ebitda
0.4706
Price Sales
160.1041
Shares Float
26.1 M
Wall Street Target Price
2.125

Leap Therapeutics Stock Price History Chart

There are several ways to analyze Leap Stock price data. The simplest method is using a basic Leap candlestick price chart, which shows Leap Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 31, 20243.74
Lowest PriceJanuary 30, 20250.52

Leap Therapeutics January 31, 2025 Stock Price Synopsis

Various analyses of Leap Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Leap Stock. It can be used to describe the percentage change in the price of Leap Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Leap Stock.
Leap Therapeutics Price Action Indicator(0.04)
Leap Therapeutics Price Rate Of Daily Change 0.91 
Leap Therapeutics Price Daily Balance Of Power(0.83)
Leap Therapeutics Accumulation Distribution 205,279 

Leap Therapeutics January 31, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Leap Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Leap Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Leap Stock and then apply it to test your longer-term investment strategies against Leap.

Leap Stock Price History Data

The price series of Leap Therapeutics for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 4.09 with a coefficient of variation of 23.51. The daily prices for the period are spread out with arithmetic mean of 2.95. The median price for the last 90 days is 2.99. The company underwent 1:10 stock split on 21st of June 2023.
OpenHighLowCloseVolume
01/30/2025 0.55  0.57  0.51  0.52  1,950,154 
01/29/2025 0.66  0.66  0.55  0.57  3,370,198 
01/28/2025 0.80  0.85  0.62  0.65  12,901,173 
01/27/2025 2.15  2.39  2.13  2.25  467,939 
01/24/2025 2.24  2.34  2.15  2.15  443,471 
01/23/2025 2.29  2.45  2.20  2.20  426,284 
01/22/2025 2.44  2.45  2.03  2.30  1,666,049 
01/21/2025 2.60  2.66  2.30  2.46  831,055 
01/17/2025 2.51  2.65  2.40  2.55  678,219 
01/16/2025 3.25  3.25  2.51  2.58  1,254,673 
01/15/2025 3.12  3.27  3.12  3.25  347,432 
01/14/2025 3.12  3.23  3.02  3.09  149,726 
01/13/2025 3.06  3.26  2.88  3.10  376,822 
01/10/2025 3.27  3.34  3.01  3.06  300,105 
01/08/2025 3.47  3.50  3.30  3.39  219,389 
01/07/2025 3.36  3.58  3.35  3.48  192,329 
01/06/2025 3.36  3.53  3.23  3.36  339,724 
01/03/2025 3.17  3.36  3.13  3.35  554,463 
01/02/2025 2.90  3.25  2.84  3.22  315,268 
12/31/2024 2.92  2.93  2.72  2.88  262,782 
12/30/2024 2.90  3.04  2.87  2.92  214,181 
12/27/2024 2.97  3.07  2.90  2.95  203,830 
12/26/2024 2.95  3.02  2.89  2.98  118,555 
12/24/2024 2.88  2.94  2.83  2.91  22,080 
12/23/2024 2.93  3.03  2.75  2.89  173,915 
12/20/2024 2.76  3.00  2.75  2.91  329,100 
12/19/2024 2.88  3.00  2.75  2.78  279,456 
12/18/2024 3.08  3.11  2.78  2.90  367,060 
12/17/2024 2.99  3.12  2.95  3.11  227,783 
12/16/2024 2.89  3.12  2.89  3.01  321,556 
12/13/2024 3.08  3.09  2.87  2.95  415,029 
12/12/2024 3.26  3.31  3.06  3.13  290,902 
12/11/2024 3.16  3.44  2.87  3.30  1,178,693 
12/10/2024 3.18  3.27  3.13  3.16  213,213 
12/09/2024 3.26  3.41  3.11  3.20  221,928 
12/06/2024 3.02  3.33  2.95  3.27  582,267 
12/05/2024 3.21  3.43  2.98  2.99  1,270,385 
12/04/2024 2.87  3.37  2.84  3.07  1,147,478 
12/03/2024 2.89  2.97  2.75  2.79  186,122 
12/02/2024 3.02  3.08  2.86  2.90  162,442 
11/29/2024 2.95  3.18  2.90  2.98  212,197 
11/27/2024 2.71  3.06  2.59  2.92  380,486 
11/26/2024 2.52  2.65  2.48  2.65  346,439 
11/25/2024 2.63  2.67  2.47  2.52  340,975 
11/22/2024 2.55  2.70  2.52  2.55  621,099 
11/21/2024 2.58  2.61  2.49  2.58  213,706 
11/20/2024 2.70  2.70  2.55  2.59  208,836 
11/19/2024 2.78  2.90  2.66  2.70  285,628 
11/18/2024 2.75  2.83  2.66  2.78  204,169 
11/15/2024 2.84  2.89  2.70  2.74  322,359 
11/14/2024 3.00  3.09  2.82  2.89  170,515 
11/13/2024 3.25  3.61  2.95  3.00  450,905 
11/12/2024 3.26  3.38  3.04  3.25  566,175 
11/11/2024 3.22  3.42  3.21  3.27  147,195 
11/08/2024 3.45  3.45  3.23  3.24  246,810 
11/07/2024 3.72  3.82  3.45  3.47  233,832 
11/06/2024 3.56  3.92  3.56  3.71  342,215 
11/05/2024 3.68  3.71  3.48  3.55  153,717 
11/04/2024 3.69  3.83  3.40  3.67  389,964 
11/01/2024 3.71  3.96  3.70  3.74  210,608 
10/31/2024 4.20  4.24  3.61  3.74  553,770 

About Leap Therapeutics Stock history

Leap Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Leap is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Leap Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Leap Therapeutics stock prices may prove useful in developing a viable investing in Leap Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding23.5 M24.7 M
Net Loss-49.1 M-46.7 M

Leap Therapeutics Quarterly Net Working Capital

47.72 Million

Leap Therapeutics Stock Technical Analysis

Leap Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Leap Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Leap Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Leap Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Leap Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Leap Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Leap to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Leap Stock Analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.